The study eases concerns about using fecal transplants in patients with compromised immune systems, for which supporting guidelines and data did not previously exist.
Lead researcher Chioma Ihunnah, MD, of Brown University in Providence, R.I., and her team found the cure rate of C. diff with a single fecal transplant to be 79 percent, which rose to 89 percent after a second transplant.
More Articles on Gastroenterology:
IBD Sufferers Often Have Limited Access to Care
Olympus Medical to Launch Updated Ultrasound Endoscopy Center in November
South Jersey Endoscopy Center Purchases HET System for Hemorrhoid Treatment
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.